CD79A and COVID-19: Previous studies have reported high IgA and IgM production in the first month after the onset of COVID-19 symptoms, as well as a marked production decrease mainly in IgM and IgA after the first month, accompanied by continued production of IgG (Jin et al., 2020; Aita et al., 2020; Sterlin et al., 2021).